News

This marks the first automated delivery system that can be used for children 2 to 6. 

The company said it has grown its business by 400% in the last three months alone.

Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.

Masimo's O3 Regional Oximeter can be integrated with its SedLine brain function monitor or its Root patient monitoring and connectivity platform. 

The new analysis of a Pear Therapeutics-based randomized controlled trial came alongside another investigation that spotted early signs of treatment dropout.

The company was founded in 2011 and is looking to go public on the Nasdaq market. 

More people experienced high blood pressure in response to the COVID-19 pandemic compared to before, according to new research from chronic care management company Livongo.

A new report from PitchBook projects solid growth in the industry, but also notes challenges in exits. 

Following a study looking into how adults living with Type 2 diabetes use technology to self-monitor lifestyle and health behaviors, researchers from the University of Texas Health Science Center at San Antonio found that technology-assisted self-monitoring was safe and effective in generating positive health outcomes.

The paper discusses the potenital for collecting real-world data, recruiting patients and using APIs.